Infective Endocarditis Clinical Trial
— EIPSLOfficial title:
Prospective Cohort Study of Patients With Infective Endocarditis Admitted at Cardiology Institute of Pitié-Salpêtrière Hospital
NCT number | NCT04992923 |
Other study ID # | APHP200685 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | September 15, 2020 |
Est. completion date | March 2041 |
Infective endocarditis (IE) is a severe condition associated with high mortality. Due to the relative low prevalence of IE, prospective data are lacking and current guidelines are mostly based on expert consensus with low level of evidence. IE is also associated with severe complications especially strokes that occur in about one third of the patients. In order to improve the management and the prognosis of IE, clinical data from larges prospective cohort studies are needed.
Status | Recruiting |
Enrollment | 700 |
Est. completion date | March 2041 |
Est. primary completion date | September 2040 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with confirmed IE according to European Society of Cardiology criteria Exclusion Criteria: - Opposition of the patient to participate |
Country | Name | City | State |
---|---|---|---|
France | APHP Pitié-Salpêtrière Hospital, Department of Cardiology | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | All-cause in hospital mortality | All-cause mortality during the length of hospital stay | up to 90 days | |
Secondary | All-cause mortality | mortality at longest follow-up | an average of 10 years | |
Secondary | symptomatic or asymptomatic systemic embolism | symptomatic or asymptomatic systemic embolism confirmed by any type of imaging during initial hospitalization | up to 90 days after inclusion | |
Secondary | Association between coagulation biomarkers (D-dimer, fibrin monomer, circulating anticoagulant, von Willebrandt factor (VWF) antigen level, von Willebrandt factor (VWF) activity) assessed at the inclusion and the presence of systemic embolism | Association between coagulation biomarkers (D-dimer, fibrin monomer, circulating anticoagulant, von Willebrandt factor (VWF) antigen level, von Willebrandt factor (VWF) activity) assessed at the inclusion and the presence of systemic embolism at the admission Initial Hospitalization | inclusion | |
Secondary | Association between coagulation biomarkers (D-dimer, fibrin monomer, circulating anticoagulant, von Willebrandt factor (VWF) antigen level, von Willebrandt factor (VWF) activity) assessed at the inclusion and the presence of systemic embolism | Association between coagulation biomarkers(D-dimer, fibrin monomer, circulating anticoagulant, von Willebrandt factor (VWF) antigen level, von Willebrandt factor (VWF) activity) assessed at the inclusion and the presence of systemic embolism within 90 days after admission | up to 90 days after inclusion | |
Secondary | heart failure, intracranial hemorrhage, or false vascular aneurysm during hospitalization | Occurrence of heart failure, intracranial hemorrhage, or false vascular aneurysm during the length of hospital stay | up to 90 days after inclusion | |
Secondary | Stroke | Stroke during the length of hospital stay | 90 days after inclusion | |
Secondary | composite criteria of stroke, Intracranial hemorrhage, hospitalization due to cardiovascular cause or IE recurrence | Occurrence of a composite criteria of stroke, Intracranial hemorrhage, hospitalization due to cardiovascular cause or IE recurrence at one year | 1 year after inclusion | |
Secondary | composite criteria of stroke, Intracranial hemorrhage, hospitalization due to cardiovascular cause or IE recurrence | Occurrence of a composite criteria of stroke, Intracranial hemorrhage, hospitalization due to cardiovascular cause or IE recurrence at the longest follow-up | through study completion, an average of 10 years | |
Secondary | composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score = 3 | on-year composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score = 3 | 1 year after inclusion | |
Secondary | composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score = 3 | Occurrence of a composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score = 3 at the longest follow-up | through study completion, an average of 10 years | |
Secondary | Association between occurrence of systemic embolism and the composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score = 3 | Association between occurrence of systemic embolism and the composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score = 3 at one year | 1 year after inclusion | |
Secondary | Occurrence of contrast-associated acute kidney injury during the length of hospital stay | rise of serum creatinine > 26.5 mcmol/L or > 50% elevation from baseline over the course of hospitalization | up to 90 days after inclusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05862025 -
Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study).
|
N/A | |
Completed |
NCT03590106 -
Cardiac Surgery Peer Recovery Support Program
|
N/A | |
Not yet recruiting |
NCT05563662 -
SURgical Registry of ENDocarditis EuRope
|
||
Completed |
NCT00947817 -
Impact of Endothelial Cell Activation and Modifications of Haemostasis Induced by Infective Endocarditis on the Risk of Embolism
|
N/A | |
Recruiting |
NCT00624091 -
Rationale, Design and Methods for the Early Surgery in Infective Endocarditis Study (ENDOVAL)
|
Phase 4 | |
Terminated |
NCT00695903 -
Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia
|
Phase 2 | |
Recruiting |
NCT03642379 -
Cardiac Surgery Peer Support Recovery
|
N/A | |
Recruiting |
NCT05264181 -
Transcatheter Pulmonary Valve Implantation With SAPIEN 3 Valve
|
||
Recruiting |
NCT04257292 -
NExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective Endocarditis
|
||
Active, not recruiting |
NCT03683355 -
Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves.
|
||
Not yet recruiting |
NCT00562653 -
Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients
|
N/A | |
Not yet recruiting |
NCT00550823 -
Cardiac Computarized Tomography in Infective Endocarditis
|
N/A | |
Completed |
NCT03153384 -
Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis
|
||
Not yet recruiting |
NCT06194409 -
The Incidence, Clinical Characteristics and Outcome of Infective Endocarditis Among Intravenous Drug Abusers Versus Non-Drug Abusers.
|
||
Completed |
NCT03945708 -
Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?
|
N/A | |
Not yet recruiting |
NCT06269679 -
CBCT vs OPT on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis.
|
N/A | |
Recruiting |
NCT03626571 -
PET/MR Imaging In Patients With Infective Endocarditis
|
||
Completed |
NCT03612245 -
Hygiene and Bucco-dental Status of Patients With Oral Streptococcal Endocarditis
|
||
Completed |
NCT02910856 -
Infective Endocarditis in the Elderly
|
||
Recruiting |
NCT02196753 -
PET CT in Suspected CIED Infection, a Pilot Study - PET Guidance I
|
N/A |